Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Josel D, Ruiz"'
Autor:
Michael Scordo, Leah J. Gilbert, Danielle M. Hanley, Jessica R. Flynn, Sean M. Devlin, Linh K. Nguyen, Josel D. Ruiz, Gunjan L. Shah, Craig S. Sauter, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Richard J. Lin, Parastoo B. Dahi, Miguel-Angel Perales, Sergio A. Giralt, Gerald A. Soff
Publikováno v:
Blood Advances. 7:1536-1544
There are no standard treatments to prevent or hasten the recovery from severe conditioning-regimen–induced thrombocytopenia occurring after autologous hematopoietic cell transplantation (auto-HCT). We conducted an open-label, single-arm pilot stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e244dffe40a0b1da09124d3c7ed78c3
https://doi.org/10.1182/bloodadvances.2022007838
https://doi.org/10.1182/bloodadvances.2022007838
Autor:
Richard J. Lin, Stephanie M. Lobaugh, Martina Pennisi, Hei Ton Chan, Yakup Batlevi, Josel D. Ruiz, Theresa A. Elko, Molly A. Maloy, Connie L. Batlevi, Parastoo B. Dahi, Sergio A. Giralt, Paul A. Hamlin, Elena Mead, Arela Noy, M. Lia Palomba, Bianca D. Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Beatriz Korc-Grodzicki, Soo Jung Kim, Mari Lynne Silverberg, Chelsea A. Brooklyn, Sean M. Devlin, Miguel-Angel Perales
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/fd167d281dcc4ce19c705f931223e5ce
Autor:
Mariam T. Nawas, Miriam Sanchez-Escamilla, Sean M. Devlin, Molly A. Maloy, Josel D. Ruiz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, Michael Scordo
Publikováno v:
Blood Advances. 6:5898-5907
Endothelial activation and stress index (EASIX) predicts nonrelapse mortality (NRM) when assessed before hematopoietic cell transplantation (HCT). We sought to determine whether changes in EASIX after HCT may be an informative marker of NRM. We evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc76cfd079ebe9feaa3ad0dc27dd8a43
https://doi.org/10.1182/bloodadvances.2022007381
https://doi.org/10.1182/bloodadvances.2022007381
Autor:
Richard J. Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M. Hanley, M. Lia Palomba, Miguel-Angel Perales, Gunjan L. Shah, Parastoo B. Dahi, Michael Scordo, Craig S Sauter, Connie Lee Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A Pavkovic, Danielle E. Engstler, Jae H. Park, Gilles A. Salles, Sean M. Devlin, Beatriz Korc-Grodzicki, Paul A. Hamlin, Sergio A. Giralt
Publikováno v:
Blood Advances.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b920965503204585656bd6041aff870a
https://doi.org/10.1182/bloodadvances.2023010003
https://doi.org/10.1182/bloodadvances.2023010003
Autor:
Andrew Lin, Samantha Brown, Molly Maloy, Josel D. Ruiz, Sean Devlin, Lauren DeRespiris, Anthony Proli, Ann A. Jakubowski, Esperanza B. Papadopoulos, Craig S. Sauter, Roni Tamari, Hugo Castro-Malaspina, Brian Shaffer, Juliet Barker, Miguel A. Perales, Sergio A. Giralt, Boglarka Gyurkocza
Publikováno v:
Leuk Lymphoma
Given prophylactic methotrexate (MTX) is often held in the setting of toxicity we investigated the impact of omitting minidose-MTX dose(s). Outcomes were compared between patients who had 1–3 doses omitted and those who received all four planned do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37bdb8b82d4ec0f9452c3eccb620e322
https://doi.org/10.1080/10428194.2022.2032036
https://doi.org/10.1080/10428194.2022.2032036
Autor:
Gunjan L. Shah, Jaap Jan Boelens, Rick Admiraal, Michael Scordo, Ryan Schofield, Andrew Lin, Roni Tamari, Anthony J. Proli, Sergio Giralt, Nancy Cruz Sitner, Anna Alperovich, Josel D. Ruiz, Dean Carlow, Parastoo B. Dahi
Publikováno v:
Clin Pharmacokinet
BACKGROUND AND OBJECTIVES High-dose melphalan is an integral part of conditioning chemotherapy prior to both autologous and allogeneic hematopoietic cell transplantation. While underexposure may lead to relapse, overexposure may lead to toxicities in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c086731a3319dbf236072eacf2e6ba1
https://doi.org/10.1007/s40262-021-01093-z
https://doi.org/10.1007/s40262-021-01093-z
Autor:
Michael Scordo, Edgar A. Jaimes, Matthew Abramson, Insara Jaffer Sathick, Junting Zheng, Molly Maloy, Josel D. Ruiz, Victoria Gutgarts
Publikováno v:
Clin J Am Soc Nephrol
Background and objectives AKI is a major complication of allogeneic hematopoietic stem cell transplantation, increasing risk of nonrelapse mortality. AKI etiology is often ambiguous due to heterogeneity of conditioning/graft versus host disease regim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea017fe19ff48bf8e655748158e03bf6
https://doi.org/10.2215/cjn.19801220
https://doi.org/10.2215/cjn.19801220
Autor:
Martina Pennisi, Miriam Sanchez-Escamilla, Molly Maloy, Virginia M. Klimek, Lucrecia Yáñez, Sergio Giralt, Josel D. Ruiz, Roni Tamari, Miguel-Angel Perales, Nerea Castillo, Hugo Castro-Malaspina, Karissa Whiting, Brian C. Shaffer, Christina Cho, Sean M. Devlin, Ana Alarcon Tomas
Publikováno v:
Bone Marrow Transplantation
The post-transplant scoring system (PTSS), developed by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy, is based on three independent post-transplant risk factors: grade of acute graft-versus-host disease, lack of platele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88effa5cbb03b956dc3d06af930388ce
https://doi.org/10.1038/s41409-021-01392-w
https://doi.org/10.1038/s41409-021-01392-w
Autor:
Miguel-Angel Perales, Molly Maloy, Sean M. Devlin, Erica Petrlik, Matthew J. Matasar, Craig H. Moskowitz, Esperanza B. Papadopoulos, Gunjan L. Shah, Josel D. Ruiz, Michael Scordo, Parastoo B. Dahi, Craig S. Sauter, Carlos Rondon-Clavo, Jasme Lee, Roni Tamari, Ann A. Jakubowski, Paul A. Hamlin, Sergio Giralt
Publikováno v:
Blood Adv
High-dose chemotherapy and autologous hematopoietic cell transplantation is an effective consolidation therapy in lymphoma; however, its use in elderly patients has been limited because of concerns for greater toxicity in this group. We investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b5302728331ca91c2b64f617199e43
https://doi.org/10.1182/bloodadvances.2020004167
https://doi.org/10.1182/bloodadvances.2020004167
Autor:
Richard J Lin, Phillip Wong, Jessica R Flynn, Erika R Ritter, Caleb Ho, Josel D Ruiz, Ann A Jakubowski, Esperanza B Papadopoulos, Brian C Shaffer, Hugo R Castro-Malaspina, Christina J Cho, Doris R Ponce, Juliet N Barker, Roni Tamari, Craig S Sauter, Boglarka Gyurkocza, Marcel van den Brink, James W Young, Miguel-Angel Perales, Sean M Devlin, Sergio A Giralt
Publikováno v:
Blood Cancer Discovery. 4:A48-A48
Introduction: Older adults with hematologic malignancies such as AML and MDS increasingly undergo allogeneic hematopoietic cell transplantation (alloHCT). The impact of the aging host environment, especially cellular senescence, remains unexplored, h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a48c12ef55f7d2c2b33647ad00119e68
https://doi.org/10.1158/2643-3249.aml23-a48
https://doi.org/10.1158/2643-3249.aml23-a48